{"id":51252,"date":"2022-11-25T15:02:21","date_gmt":"2022-11-25T14:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-america-human-papillomavirus-vaccine-market-report-2022-increase-in-prevalence-of-hpv-associated-diseases-spurs-growth-researchandmarkets-com\/"},"modified":"2022-11-25T15:02:21","modified_gmt":"2022-11-25T14:02:21","slug":"north-america-human-papillomavirus-vaccine-market-report-2022-increase-in-prevalence-of-hpv-associated-diseases-spurs-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-america-human-papillomavirus-vaccine-market-report-2022-increase-in-prevalence-of-hpv-associated-diseases-spurs-growth-researchandmarkets-com\/","title":{"rendered":"North America Human Papillomavirus Vaccine Market Report 2022: Increase in Prevalence of HPV Associated Diseases Spurs Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “North America Human Papillomavirus Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Dosage, Age, Application, and End User”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe North America human papillomavirus (HPV) vaccine market is expected to grow from US$ 2,247.18 million in 2022 to US$ 2,964.96 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2022 to 2028.\n<\/p>\n

\nThe increase in programs for HPV awareness is one of the effective strategies to increase vaccination uptake and eliminate HPV-associated cancers. Dana-Farber Cancer Institute, Boston, US, has initiated the HPV and Related Cancers Outreach Program, which aims to reduce the HPV-related cancer burden in the community through education and vaccination. The outreach program has been developed to address common barriers to vaccination.\n<\/p>\n

\nThrough workshops with the City of Boston and the Boston Public Health Commission, youth-serving organizations, Boston Public Schools, Area Health Education Centers organizations, and faith-based and other community-based organizations, people in Boston have been educated about it. Therefore, the growing number of awareness programs is likely to fuel the market growth in the next few years.\n<\/p>\n

\nWith the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America human papillomavirus (HPV) vaccine market . The North America human papillomavirus (HPV) vaccine market is expected to grow at a good CAGR during the forecast period.\n<\/p>\n

\nNorth America Human Papillomavirus (HPV) Vaccine Market Segmentation<\/strong>\n<\/p>\n

\nThe North America human papillomavirus (HPV) vaccine market is segmented based on type, dosage, age, application, end user, and country.\n<\/p>\n